Phenominer Database Results (45 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
WKY/N mean corpuscular volume control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 erythrocyte size trait both 132 days-139 days 208 63.3 fl 0.06 0.8 automated blood cell counting method 0 0 65923 114
WKY/N body weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. body mass male 84 days 15 399.0 g 16.0 61.97 body weighing method 0 13062 327
WKY/N heart weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass male 84 days 15 2.99 g/kg 0.08 0.31 post excision weight measurement 0 13065 327
WKY/N systolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait female 84 days 22 130.0 mmHg 5.0 23.45 vascular fluid filled catheter right carotid 0 13067 327
WKY/N heart left ventricle wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass female 84 days 22 0.59 g 0.05 0.24 post excision weight measurement 0 13072 327
WKY/N kidney glomerular lesion count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney glomerulus integrity trait male 126 days-182 days 0 0.8 /section 0.5 ex vivo light microscopy with histochemistry renal glomerulus 0.0 0 107537 3090
WKY/N kidney tubule regeneration foci count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126 days-182 days 0 0.25 /section 0.25 ex vivo light microscopy with histochemistry 0.0 0 107545 3090
WKY/N kidney tubule regeneration foci count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210 days-224 days 0 0.5 /section 0.4 ex vivo light microscopy with histochemistry 0.0 0 foci of tubular regeneration 107483 3088
WKY/N interstitial nephritis foci count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210 days-224 days 0 0.9 /section 0.4 ex vivo light microscopy with histochemistry 0.0 0 foci of interstitial nephritis 107487 3088
WKY/N heart wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass male 84 days 15 1.2 g 0.05 0.21 post excision weight measurement 0 13063 327
WKY/N systolic blood pressure control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 arterial blood pressure trait both 125 days-132 days 220 143.0 mmHg 0.74 11.0 tail cuff piezoplethysmography 0 6-8 readings per sitting 11672 114
WKY/N hematocrit control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 erythrocyte quantity both 132 days-139 days 208 56.3 % 0.31 4.4 automated blood cell counting method 0 0 65911 114
WKY/N white blood cell count control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 leukocyte quantity both 132 days-139 days 208 4.7 x 1000 cells/ul 0.06 0.8 automated total white blood cell count test 0 0 65941 114
WKY/N body weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. body mass female 84 days 22 353.0 g 19.0 89.12 body weighing method 0 13070 327
WKY/N ratio of deaths related to chronic hypertension to total study population during a period of time control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. total life span male 168 days-189 days 25 0.0 % unspecified method 0.0 0 ratio of deaths related to chronic hypertension to total study population during a period of time (CMO:0003800) 107516 3090
WKY/N renal fibrosis foci count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126 days-182 days 0 5.9 /section 0.7 ex vivo light microscopy with histochemistry 0.0 0 107557 3090
WKY/N systolic blood pressure control condition Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. arterial blood pressure trait both 180 days-270 days 9 109.0 mmHg 7.0 21.0 tail cuff plethysmography 0.0 0 107636 3094
WKY/N urine total protein excretion rate control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. urine protein amount male 210 days-224 days 0 18.0 mg/d 2.0 urine protein analysis 86400.0 0 metabolic cage; sulfosalicylic acid method 107471 3088
WKY/N net potassium efflux to blood lymphocyte dry weight ratio per unit time control condition Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. potassium ion homeostasis trait both 180 days-270 days 9 7.38 mmol/kg/h 2.3 6.9 flame photometry 0.0 0 107642 3094
WKY/N heart wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass female 84 days 22 0.9 g 0.07 0.33 post excision weight measurement 0 13071 327
WKY/N heart left ventricle weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass female 84 days 22 1.68 mg/g 0.14 0.66 post excision weight measurement 0 13074 327
WKY/N red blood cell count control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 erythrocyte quantity both 132 days-139 days 208 8.89 x 10E6 cells/ul 0.04 0.64 automated blood cell counting method 0 0 65935 114
WKY/N systolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait male 84 days 15 129.0 mmHg 8.0 30.98 vascular fluid filled catheter right carotid 0 13059 327
WKY/N mean arterial blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait male 84 days 15 110.0 mmHg 8.0 30.98 vascular fluid filled catheter right carotid 0 13061 327
WKY/N body weight control condition (for 42 days) Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. body mass male 126 days-147 days 0 309.0 g 8.0 body weighing method 0.0 0 107525 3090
WKY/N both kidneys wet weight to body weight ratio control condition (between 42 and 77 days) Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney mass male 126 days-182 days 0 6.1 g/kg 0.4 post excision weight measurement kidney 0.0 0 107533 3090
WKY/N kidney total tubule cast count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126 days-182 days 0 1.0 /section 1.0 ex vivo light microscopy with histochemistry 0.0 0 107553 3090
WKY/N kidney glomerular lesion count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney glomerulus integrity trait male 210 days-224 days 0 0.5 /section 0.4 ex vivo light microscopy with histochemistry 0.0 0 107475 3088
WKY/N interstitial nephritis foci count control condition Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney integrity trait male 126 days-182 days 0 0.5 /section 0.3 ex vivo light microscopy with histochemistry 0.0 0 107549 3090
WKY/N kidney total tubule cast count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210 days-224 days 0 0.6 /section 0.3 ex vivo light microscopy with histochemistry 0.0 0 total tubular casts 107491 3088
WKY/N blood hemoglobin level control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 blood hemoglobin amount both 132 days-139 days 208 16.1 g/dl 0.08 1.2 automated blood cell counting method 0 0 65917 114
WKY/N platelet count control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 platelet quantity both 132 days-139 days 208 741.0 x 1000 cells/ul 4.16 60.0 automated blood cell counting method 0 0 65929 114
WKY/N heart left ventricle wet weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass male 84 days 15 0.79 g 0.04 0.17 post excision weight measurement 0 13064 327
WKY/N both adrenal glands weight to body weight ratio control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 adrenal gland mass both 167 days-174 days 210 21.6 mg/100g 0.23 3.4 post excision weight measurement 0 0 65994 114
WKY/N heart weight to body weight ratio control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 heart mass both 167 days-174 days 45 3.96 g/kg 0.04 0.25 post excision weight measurement 0 0 66000 114
WKY/N renal fibrosis foci count control condition Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. kidney integrity trait male 210 days-224 days 0 16.0 /section 1.0 ex vivo light microscopy with histochemistry 0.0 0 foci of renal fibrosis 107495 3088
WKY/N diastolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait male 84 days 15 91.0 mmHg 8.0 30.98 vascular fluid filled catheter right carotid 0 13060 327
WKY/N both adrenal glands wet weight control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 adrenal gland mass both 167 days-174 days 210 45.7 mg 0.32 4.6 post excision weight measurement 0 0 65988 114
WKY/N mean arterial blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait female 84 days 22 117.0 mmHg 5.0 23.45 vascular fluid filled catheter right carotid 0 13069 327
WKY/N heart weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart mass female 84 days 22 2.55 g/kg 0.24 1.13 post excision weight measurement 0 13073 327
WKY/N kidney weight control condition (between 42 and 77 days) Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. kidney mass male 126 days-182 days 0 2.18 g 0.08 post excision weight measurement kidney 0.0 0 107529 3090
WKY/N net sodium influx to blood lymphocyte dry weight ratio per unit time control condition Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. sodium ion homeostasis trait both 180 days-270 days 11 5.12 mmol/kg/h 2.6 8.62 flame photometry 0.0 0 107640 3094
WKY/N heart left ventricle weight to body weight ratio control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. heart left ventricle mass male 84 days 15 1.99 mg/g 0.08 0.31 post excision weight measurement 0 13066 327
WKY/N diastolic blood pressure control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. arterial blood pressure trait female 84 days 22 103.0 mmHg 9.0 42.21 vascular fluid filled catheter right carotid 0 13068 327
WKY/N body weight control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 body mass both 70 days 220 215.0 g 1.36 20.1 body weighing method 0 0 66008 114